Sirio Pharma Co., Ltd. (SHE:300791)
China · Delayed Price · Currency is CNY 17.55
+0.57 (3.36%)
Aug 25, 2026, 10:45 AM CST
Sirio Pharma Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 636.42 | 595.14 | 636.03 | 534.49 | 1,502 | 715.54 |
Short-Term Investments | 97.56 | 98.2 | 25.17 | 20 | 109.26 | - |
Trading Asset Securities | 32.89 | 5 | 115.2 | 200.66 | 79.13 | 530.77 |
Cash & Short-Term Investments | 766.87 | 698.34 | 776.4 | 755.14 | 1,690 | 1,246 |
Cash Growth | 9.08% | -10.05% | 2.81% | -55.32% | 35.60% | 80.57% |
Accounts Receivable | 708.99 | 691.26 | 702.53 | 652.86 | 476.96 | 372.33 |
Other Receivables | 6.61 | 11.58 | 20.81 | 4.99 | 4.45 | 4.27 |
Receivables | 715.6 | 702.84 | 723.34 | 657.85 | 481.41 | 376.6 |
Inventory | 471.6 | 458.24 | 481.66 | 481.06 | 232.58 | 239.61 |
Other Current Assets | 57.43 | 62.8 | 41.54 | 38.87 | 28.58 | 51.99 |
Total Current Assets | 2,011 | 1,922 | 2,023 | 1,933 | 2,433 | 1,915 |
Property, Plant & Equipment | 2,241 | 2,192 | 2,093 | 1,913 | 1,332 | 1,173 |
Long-Term Investments | 163.53 | 166.57 | 52.44 | 94.11 | - | 337.79 |
Goodwill | 425.46 | 427.11 | 417.1 | 420.73 | 163.05 | 158.59 |
Other Intangible Assets | 442.8 | 459.89 | 525.92 | 544.84 | 178.33 | 160.75 |
Long-Term Deferred Tax Assets | 166.6 | 147.12 | 81.36 | 32.48 | 13.75 | 16.31 |
Long-Term Deferred Charges | 199.73 | 207.61 | 258.14 | 201.92 | 59.45 | 53 |
Other Long-Term Assets | 68.2 | 68.52 | 34.66 | 55.99 | 7.14 | 6.57 |
Total Assets | 5,719 | 5,591 | 5,486 | 5,196 | 4,186 | 3,820 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Accounts Payable | 388.91 | 438.96 | 393.43 | 398.13 | 259.25 | 195.71 |
Accrued Expenses | 76.38 | 190.08 | 191.85 | 104.39 | 152.33 | 79.6 |
Short-Term Debt | 183.77 | 118.68 | 54.82 | - | 0.16 | 0.12 |
Current Portion of Long-Term Debt | 100.51 | 97.02 | 40.59 | 21.25 | - | - |
Current Portion of Leases | - | 23.37 | 27.09 | 42.8 | 7.26 | 5.19 |
Current Income Taxes Payable | 47.55 | 35.33 | 48.07 | 11.39 | 11.03 | 10.18 |
Current Unearned Revenue | 44.51 | 43.32 | 36.92 | 53.13 | 25.83 | 28.22 |
Other Current Liabilities | 248.3 | 113.35 | 31.76 | 120.04 | 13.84 | 13.43 |
Total Current Liabilities | 1,090 | 1,060 | 824.54 | 751.13 | 469.69 | 332.44 |
Long-Term Debt | 1,213 | 1,137 | 1,156 | 1,049 | 908.36 | 852.28 |
Long-Term Leases | 312.79 | 307.41 | 328.39 | 256.16 | 21.14 | 16.68 |
Long-Term Unearned Revenue | 96.29 | 98.17 | 59.7 | 65.68 | 62.4 | 61.48 |
Long-Term Deferred Tax Liabilities | 38.35 | 26.75 | 15.15 | 28.08 | 22.69 | 12.44 |
Other Long-Term Liabilities | 2.14 | 1.76 | 461.44 | 479.47 | 0.01 | - |
Total Liabilities | 2,752 | 2,631 | 2,845 | 2,630 | 1,484 | 1,275 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Common Stock | 307.64 | 307.63 | 235.87 | 181.56 | 180.5 | 180.17 |
Additional Paid-In Capital | 913.81 | 905.92 | 500.7 | 547.5 | 1,048 | 1,045 |
Retained Earnings | 1,657 | 1,607 | 1,623 | 1,496 | 1,278 | 1,138 |
Treasury Stock | -69.34 | -69.22 | -54.31 | -44.53 | - | - |
Comprehensive Income & Other | 149.2 | 191.3 | 200.88 | 209.37 | 195.13 | 181.35 |
Total Common Equity | 2,958 | 2,942 | 2,506 | 2,390 | 2,702 | 2,545 |
Minority Interest | 9.09 | 17.06 | 135.36 | 176.14 | - | 0.01 |
Shareholders' Equity | 2,967 | 2,959 | 2,641 | 2,566 | 2,702 | 2,545 |
Total Liabilities & Equity | 5,719 | 5,591 | 5,486 | 5,196 | 4,186 | 3,820 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Total Debt | 1,810 | 1,684 | 1,607 | 1,369 | 936.9 | 874.26 |
Net Cash (Debt) | -1,043 | -985.26 | -830.1 | -614.1 | 753.08 | 372.05 |
Net Cash Growth | - | - | - | - | 102.42% | -43.24% |
Net Cash Per Share | -3.41 | -3.22 | -2.73 | -2.02 | 2.45 | 1.16 |
Filing Date Shares Outstanding | 304.86 | 306.19 | 306.79 | 304.67 | 305.04 | 304.49 |
Total Common Shares Outstanding | 304.86 | 306.19 | 304.96 | 304.67 | 305.04 | 304.49 |
Working Capital | 921.58 | 862.1 | 1,198 | 1,182 | 1,963 | 1,582 |
Book Value Per Share | 9.70 | 9.61 | 8.22 | 7.84 | 8.86 | 8.36 |
Tangible Book Value | 2,090 | 2,055 | 1,563 | 1,424 | 2,360 | 2,225 |
Tangible Book Value Per Share | 6.85 | 6.71 | 5.12 | 4.68 | 7.74 | 7.31 |
Buildings | - | 1,322 | 1,067 | 1,000 | 890.28 | 528.67 |
Machinery | - | 1,550 | 1,390 | 1,242 | 974.19 | 773.89 |
Construction In Progress | - | 168.85 | 238.4 | 186.94 | 69.28 | 365.12 |